SKU: T77117-1mg-TM

Toripalimab

In Stock Blue Ice

Specifications

Specification	Details
Additional Information	Toripalimab, the first domestic anti-tumor PD-1 antibody in China, is a selective, recombinant, humanized monoclonal antibody that targets PD-1. By binding to PD-1, it inhibits interactions with its ligands, demonstrating primary anti-tumor efficacy in various tumors, including melanoma, lung cancer, digestive tract tumors, hepatobiliary and pancreatic tumors, neuroendocrine neoplasms, nasopharyngeal carcinoma, and urothelial carcinoma [1].

Specification

Details

Additional Information

Toripalimab, the first domestic anti-tumor PD-1 antibody in China, is a selective, recombinant, humanized monoclonal antibody that targets PD-1. By binding to PD-1, it inhibits interactions with its ligands, demonstrating primary anti-tumor efficacy in various tumors, including melanoma, lung cancer, digestive tract tumors, hepatobiliary and pancreatic tumors, neuroendocrine neoplasms, nasopharyngeal carcinoma, and urothelial carcinoma [1].

Resources

PDF

Datasheet

Catalog Number

T77117-1mg-TM

Name

Toripalimab

Price(100 mg)

← Back to products